Related Experiment Video

Updated: Jul 15, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

Restoration of RUNX3 enhances transforming growth factor-beta-dependent p21 expression in a biliary tract cancer cell

Kazunori Hasegawa1, Shujiro Yazumi, Manabu Wada

  • 1Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, 606-8507, Japan.

Cancer Science
|May 2, 2007
PubMed

Insights

RUNX3, a tumor suppressor gene, enhances transforming growth factor-beta signaling in biliary tract cancer cells. This leads to cell cycle arrest and reduced tumor growth, highlighting RUNX3

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • RUNX3 is a candidate tumor suppressor gene located at 1p36, a region frequently altered in human cancers.
  • Biliary tract cancer (BTC) often involves genetic alterations in tumor suppressor pathways.
  • The role of RUNX3 in transforming growth factor (TGF)-beta signaling within BTC remains to be fully elucidated.

Purpose of the Study:

  • To investigate the function of RUNX3 in TGF-beta signaling pathways in biliary tract cancer.
  • To determine if RUNX3 influences TGF-beta-mediated cell cycle arrest and growth inhibition in BTC cells.
  • To assess the impact of RUNX3 expression on the tumorigenicity of BTC cells in vivo.

Main Methods:

  • Transfection of Mz-ChA-2 biliary tract cancer cells (RUNX3-negative) with a RUNX3 expression plasmid.
  • Assessment of cell proliferation, cell cycle progression (G1 arrest), and apoptosis following TGF-beta1 treatment.
  • Analysis of key cell cycle regulatory proteins, including p21, cyclin D1, and cyclin E.
  • Evaluation of tumorigenicity using xenograft models in nude mice.

Main Results:

  • RUNX3 transfection significantly enhanced TGF-beta1-induced growth inhibition and G1 arrest in Mz-ChA-2 cells.
  • RUNX3 overexpression led to increased TGF-beta1-induced p21 expression and decreased cyclin D1/E levels.
  • RUNX3 knockdown partially reversed the TGF-beta1-dependent p21 induction.
  • Tumorigenicity in nude mice was inversely correlated with RUNX3 expression levels.

Conclusions:

  • RUNX3 plays a crucial role in mediating TGF-beta-induced G1 cell cycle arrest in biliary tract cancer.
  • RUNX3 contributes to the tumor suppressive effects of TGF-beta signaling by regulating p21 expression.
  • RUNX3 expression is inversely associated with tumorigenicity, suggesting its potential as a therapeutic target in BTC.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...